Boothbay Fund Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 1385 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1468 |
|
|
2023
Q4 | – | Sell |
-2,300
| Closed | -$451K | – | 1529 |
|
|
2023
Q3 | $451K | Buy |
+2,300
| New | +$451K | 0.01% | 897 |
|
|
2023
Q2 | – | Sell |
-4,346
| Closed | -$877K | – | 1654 |
|
|
2023
Q1 | $877K | Buy |
4,346
+3,346
| +335% | +$675K | 0.02% | 879 |
|
|
2022
Q4 | $218K | Buy |
+1,000
| New | +$218K | 0.01% | 1329 |
|
|
2022
Q3 | – | Sell |
-7,215
| Closed | -$1.54M | – | 1987 |
|
|
2022
Q2 | $1.54M | Buy |
+7,215
| New | +$1.54M | 0.04% | 575 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1942 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1731 |
|
|
2021
Q3 | – | Sell |
-572
| Closed | -$212K | – | 1695 |
|
|
2021
Q2 | $212K | Buy |
+572
| New | +$212K | 0.01% | 1320 |
|
|
2020
Q2 | – | Sell |
-6,235
| Closed | -$787K | – | 861 |
|
|
2020
Q1 | $787K | Sell |
6,235
-8,205
| -57% | -$1.04M | 0.07% | 305 |
|
|
2019
Q4 | $2.21M | Sell |
14,440
-2,455
| -15% | -$375K | 0.19% | 116 |
|
|
2019
Q3 | $2.24M | Buy |
+16,895
| New | +$2.24M | 0.21% | 96 |
|
|
2016
Q4 | – | Sell |
-8,086
| Closed | -$674K | – | 710 |
|
|
2016
Q3 | $674K | Sell |
8,086
-576
| -7% | -$48K | 0.15% | 117 |
|
|
2016
Q2 | $714K | Sell |
8,662
-2,236
| -21% | -$184K | 0.28% | 72 |
|
|
2016
Q1 | $828K | Buy |
10,898
+4,708
| +76% | +$358K | 0.62% | 16 |
|
|
2015
Q4 | $498K | Buy |
6,190
+287
| +5% | +$23.1K | 0.22% | 86 |
|
|
2015
Q3 | $375K | Buy |
5,903
+2,773
| +89% | +$176K | 0.18% | 117 |
|
|
2015
Q2 | $220K | Buy |
+3,130
| New | +$220K | 0.09% | 243 |
|